Immunovant IMVT Q1 2026 Earnings NarrowerThanExpected Loss but EPS Miss Highlights RD Spending CF Industries Q1 2026 Earnings EPS Beats Expectations Amidst Stable Operations ZTS Q1 2026 Earnings EPS Misses Estimates Stock Declines 134 DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress Theriva Biologics TOVX Q1 2026 Earnings Slight EPS Beat Boosts Sentiment for ClinicalStage Biotech CHA Q4 2025 Earnings Significant EPS Miss Sends Shares Lower Amid Broader Challenges